Consun Pharmaceutical Group Ltd
HKEX:1681
Wall Street
Price Targets
Price Targets Summary
Consun Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for Consun Pharmaceutical Group Ltd is 9.69 HKD with a low forecast of 7.17 HKD and a high forecast of 12.5 HKD.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Consun Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for Consun Pharmaceutical Group Ltd's operating income is 15%. The projected CAGR for the next 2 years is 16%.
Net Income
Forecast
Net Income Estimate
Consun Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for Consun Pharmaceutical Group Ltd's net income is 15%. The projected CAGR for the next 3 years is 10%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Consun Pharmaceutical Group Ltd's stock price target?
Price Target
9.69
HKD
According to Wall Street analysts, the average 1-year price target for Consun Pharmaceutical Group Ltd is 9.69 HKD with a low forecast of 7.17 HKD and a high forecast of 12.5 HKD.
What is Consun Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Consun Pharmaceutical Group Ltd's revenue is 15%. The projected CAGR for the next 3 years is 10%.
What is Consun Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for Consun Pharmaceutical Group Ltd's operating income is 15%. The projected CAGR for the next 2 years is 16%.
What is Consun Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Consun Pharmaceutical Group Ltd's net income is 15%. The projected CAGR for the next 3 years is 10%.